Lipoproteins as modulators of atherothrombosis: From endothelial function to primary and secondary coagulation

Ouweneel, A.B.; Eck, M. van (2016)

Article / Letter to editor

Atherothrombosis is a complication of atherosclerosis that causes acute cardiovascular events such as myocardial infarction and stroke. Circulating lipid levels are highly correlated with atherosclerotic plaque development. In addition, experimental evidence suggests that lipids also directly influence thrombosis and influence the risk and the outcome of acute cardiovascular events. Plasma lipoproteins influence three aspects important to atherothrombosis: endothelial function, platelet aggregation (primary coagulation) and secondary coagulation. Overall, VLDL, LDL and oxLDL promote thrombus formation, whereas HDL shows antithrombotic actions. In this review we will address the current knowledge about modulation of atherothrombosis by lipoproteins, summarizing findings from in vitro and in vivo animal studies, as well as from observational and interventional studies in humans. We will conclude with future perspectives for lipid modulation in the prevention of atherothrombosis.

• Atherothrombosis
• Lipoproteins
• Endothelial function
• Platelets
• Coagulation

• All authors: Ouweneel, A.B.; Eck, M. van
• Date: 2016-07-31
• Volume: 82
• Pages: 1 - 10
• DOI: doi:10.1016/j.vph.2015.10.009